TirzaSema has no affiliate relationship with 24hrDoc as of September 24, 2026.
24hrDoc’s current public home page describes general virtual access to doctors and other medical professionals. It did not provide a clear current weight-loss program or pricing in the pages checked. The FDA issued a February 20, 2026 warning letter addressing false or misleading claims concerning compounded semaglutide and tirzepatide product pages. Published pricing: No current, transparent weight-management or GLP-1 price was verified on the public 24hrDoc home page. The service advertises general telehealth consultations; ask whether a specific weight-care service is available and request written pricing before payment. This assessment focuses on the defined service, price visibility, access and policies—not clinical efficacy. We reviewed publicly available materials and did not purchase or test the service. This profile should not be read as a current GLP-1 offer or endorsement. The FDA letter cited specific claims and labels on the company’s website at that time. Before relying on any present medical service, confirm current scope and licensing, and review the FDA letter and any company response. This editorial review is not a clinical recommendation or a guarantee of service availability.
24hrDoc’s current public home page describes general virtual access to doctors and other medical professionals. It did not provide a clear current weight-loss program or pricing in the pages checked. The FDA issued a February 20, 2026 warning letter addressing false or misleading claims concerning compounded semaglutide and tirzepatide product pages.
The key question is what happens after the website intake: who reviews the information, whether that person is a licensed clinician, which company provides the medical service, where any prescription is dispensed, and how follow-up is handled. A completed questionnaire, eligibility screen or payment does not guarantee a prescription, diagnosis, test result or treatment.
No current, transparent weight-management or GLP-1 price was verified on the public 24hrDoc home page. The service advertises general telehealth consultations; ask whether a specific weight-care service is available and request written pricing before payment.
| Cost element | Check before purchase |
|---|---|
| Price shown | Is it a recurring monthly amount, first-month offer, test kit price or monthly equivalent? |
| Total commitment | How much is charged now, and what is the full cost over the treatment or testing period? |
| Included care | Are clinician review, labs, medication, supplies, shipping and follow-up included? |
| Renewal and refunds | When does billing recur, how do you cancel and what is refundable after fulfillment? |
This profile should not be read as a current GLP-1 offer or endorsement. The FDA letter cited specific claims and labels on the company’s website at that time. Before relying on any present medical service, confirm current scope and licensing, and review the FDA letter and any company response. The source links identify where each current offer was checked. Verify the exact product and final checkout amount because catalog rates, promotions and eligibility can change.
Confirm state coverage and whether the service is direct-pay, insurance-billed, employer-sponsored or an at-home test purchase. For prescription care, ask who makes the decision and how to reach that clinician. For laboratory testing, check specimen type, turnaround time, result interpretation and whether a positive or inconclusive result includes follow-up. Health services are not interchangeable simply because they appear in the same directory category.
The FDA’s February 20, 2026 warning letter to 24HrDoc addresses statements and product labeling for compounded semaglutide and tirzepatide shown on the company website at that time. It is an important documented regulatory event; the linked letter should be read directly for the cited conduct. The current home page checked for this review describes general virtual care and does not provide a transparent current GLP-1 menu or price. We therefore do not present 24hrDoc as a currently verified GLP-1 seller.
For any prescription or diagnostic service, confirm the product or test’s intended use, clinician oversight, contraindications, privacy practices and follow-up plan. Test results and testimonials should not replace a clinician’s interpretation. Do not start, stop or change treatment without medical advice.
Ratings use the same editorial weights across the directory: cost clarity 30%, product or medication clarity 20%, care and safety disclosure 20%, access 15%, and support/policy clarity 15%. This is a review of what is publicly documented, not a medical-quality or efficacy score.
| Category | Score | Weight | Assessment |
|---|---|---|---|
| Cost and price transparency | 2.0/10 | 30% | Published prices, billing frequency and full-term clarity. |
| Medication options and sourcing | 2.0/10 | 20% | Clarity about service scope, product or test and sourcing. |
| Medical care and safety | 3.0/10 | 20% | Provider involvement, safety information and limitations. |
| Ease of use and access | 5.0/10 | 15% | Availability, enrollment and practical access. |
| Customer support and policies | 3.0/10 | 15% | Policy clarity and breadth of public feedback. |
Weighted score: 2.8/10. The underlying factors are shown so readers can see which published details raised or lowered the rating.
Trustpilot lists 24hrDoc at 4.2/5 from 15,594 reviews. This profile covers the company’s broader telehealth business, not a verified current GLP-1 or weight-management program. Consult the official service terms and independent regulatory or licensing records as appropriate.
| Decision | 24hrDoc | Other routes to compare |
|---|---|---|
| Primary use | 24hrDoc’s current public home page describes general virtual access to doctors and other medical professionals. It did not provide a clear current weight-loss program or pricing in the pages checked. The FDA issued a February 20, 2026 warning letter addressing false or misleading claims concerning compounded semaglutide and tirzepatide product pages. | Compare only providers or tests serving the same need; diagnostics, prescription care and employer benefits are different products. |
| Price model | No current, transparent weight-management or GLP-1 price was verified on the public 24hrDoc home page. The service advertises general telehealth consultations; ask whether a specific weight-care service is available and request written pricing before payment. | Compare the final total and what is included rather than headline monthly numbers. |
| Clinical follow-up | Check the provider, test interpretation or response path described above. | Confirm access to an appropriately licensed clinician and what happens if a result or side effect needs attention. |
| Evidence | Company claims and consumer reviews have separate limits. | Check regulatory information, product labeling and peer-reviewed evidence relevant to the actual product. |
24hrDoc’s current public home page describes general virtual access to doctors and other medical professionals. It did not provide a clear current weight-loss program or pricing in the pages checked. The FDA issued a February 20, 2026 warning letter addressing false or misleading claims concerning compounded semaglutide and tirzepatide product pages.
No current, transparent weight-management or GLP-1 price was verified on the public 24hrDoc home page. The service advertises general telehealth consultations; ask whether a specific weight-care service is available and request written pricing before payment. Check the selected plan and complete charge before placing an order.
No. Where clinical care is involved, an appropriately licensed clinician determines what is suitable. Testing and consumer feedback do not diagnose or predict treatment outcomes.
Confirm service scope, applicable state availability, provider or lab roles, total cost, billing and cancellation terms, privacy and how follow-up questions will be handled.
Official pages and the matching public profile were reviewed on September 24, 2026. Company pages establish what the brand currently states; they are not independent confirmation of clinical claims. Where a regulator’s document is linked, its scope is stated specifically.
Trustpilot: 4.2/5 from 15,594 reviews. The rating covers the broader company service and should not be read as a weight-loss-specific rating.
We read the official service, pricing, FAQ and policy pages linked above and checked the matching Trustpilot page only when identity and rating were clear. We did not order products, submit a medical intake, perform laboratory testing or assess a patient outcome. Each score is calculated from the displayed five categories and their stated weights. Prices, state availability and terms can change.
24hrDoc’s current public home page describes general virtual access to doctors and other medical professionals. It did not provide a clear current weight-loss program or pricing in the pages checked. The FDA issued a February 20, 2026 warning letter addressing false or misleading claims concerning compounded semaglutide and tirzepatide product pages. Published pricing: No current, transparent weight-management or GLP-1 price was verified on the public 24hrDoc home page. The service advertises general telehealth consultations; ask whether a specific weight-care service is available and request written pricing before payment. This assessment focuses on the defined service, price visibility, access and policies—not clinical efficacy. We reviewed publicly available materials and did not purchase or test the service. This profile should not be read as a current GLP-1 offer or endorsement. The FDA letter cited specific claims and labels on the company’s website at that time. Before relying on any present medical service, confirm current scope and licensing, and review the FDA letter and any company response. Review the sources, confirm the written terms directly, and consult an appropriately licensed professional for medical questions.
24hrDoc’s current public home page describes general virtual access to doctors and other medical professionals. It did not provide a clear current weight-loss program…